{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:12:41Z","timestamp":1780416761038,"version":"3.54.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s13555-020-00456-x","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T16:03:58Z","timestamp":1602518638000},"page":"1415-1421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Patient-Reported Ocular Disorders and Symptoms in Adults with Moderate-to-Severe Atopic Dermatitis: Screening and Baseline Survey Data from a Clinical Trial"],"prefix":"10.1007","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct02260986","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jonathan","family":"Weyne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Blauvelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"de Bruin-Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Errol","family":"Prens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Asbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Sierka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Shumel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"key":"456_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jaad.2017.03.003","volume":"77","author":"JP Thyssen","year":"2017","unstructured":"Thyssen JP, Toft PB, Halling-Overgaard A-S, Gislason GH, Skov L, Egeberg A. Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis. J Am Acad Dermatol. 2017;77:280\u20136.","journal-title":"J Am Acad Dermatol"},{"key":"456_CR2","unstructured":"US Department of Health and Human Services Public Health Service, National Center for Health Statistics. Eye conditions and related need for medical care among persons 1\u201374 years of age: United States, 1971\u201372. DHHS Publication No. (PHS) 83\u20131678. 1983. https:\/\/www.cdc.gov\/nchs\/data\/series\/sr_11\/sr11_228.pdf. Accessed 11 Feb 2020."},{"key":"456_CR3","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s40257-019-00455-5","volume":"20","author":"KM Beck","year":"2019","unstructured":"Beck KM, Seitzman GD, Yang EJ, Sanchez IM, Liao W. Ocular co-morbidities of atopic dermatitis. Part 1: associated ocular diseases. Am J Clin Dermatol. 2019;20:797\u2013805.","journal-title":"Am J Clin Dermatol"},{"key":"456_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jaad.2013.10.036","volume":"70","author":"JJ Chen","year":"2014","unstructured":"Chen JJ, Applebaum DS, Sun GS, Pflugfelder SC. Atopic keratoconjunctivitis: a review. J Am Acad Dermatol. 2014;70:569\u201375.","journal-title":"J Am Acad Dermatol"},{"key":"456_CR5","first-page":"21","volume":"19","author":"JA Garrity","year":"1984","unstructured":"Garrity JA, Liesegang TJ. Ocular complications of atopic dermatitis. Can J Ophthalmol. 1984;19:21\u20134.","journal-title":"Can J Ophthalmol"},{"key":"456_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/bjo.82.1.82","volume":"82","author":"E Uchio","year":"1998","unstructured":"Uchio E, Miyakawa K, Ikezawa Z, Ohno S. Systemic and local immunological features of atopic dermatitis patients with ocular complications. Br J Ophthalmol. 1998;82:82\u20137.","journal-title":"Br J Ophthalmol"},{"key":"456_CR7","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jaip.2018.10.009","volume":"7","author":"K Govind","year":"2019","unstructured":"Govind K, Whang K, Khanna R, et al. Atopic dermatitis is associated with increased prevalence of multiple ocular comorbidities. J Allergy Clin Immunol. 2019;7:298\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"456_CR8","first-page":"796","volume":"43","author":"N Ohmachi","year":"1994","unstructured":"Ohmachi N, Sasabe T, Kojima M, et al. Eye complications in atopic dermatitis. Areruga. 1994;43:796\u20139 (article in Japanese).","journal-title":"Areruga"},{"key":"456_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.iac.2010.06.004","volume":"30","author":"B Bielory","year":"2010","unstructured":"Bielory B, Bielory L. Atopic dermatitis and keratoconjunctivitis. Immunol Allergy Clin N Am. 2010;30:323\u201336.","journal-title":"Immunol Allergy Clin N Am"},{"key":"456_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-4362.1994.tb01484.x","volume":"33","author":"VN Sehgal","year":"1994","unstructured":"Sehgal VN, Jain S. Atopic dermatitis: ocular changes. Int J Dermatol. 1994;33:11\u20135.","journal-title":"Int J Dermatol"},{"key":"456_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/00004397-198502510-00005","volume":"25","author":"LF Rich","year":"1985","unstructured":"Rich LF, Hanifin JM. Ocular complications of atopic dermatitis and other eczemas. Int Ophthalmol Clin. 1985;25:61\u201376.","journal-title":"Int Ophthalmol Clin"},{"key":"456_CR12","first-page":"145","volume":"24","author":"LS Braude","year":"1984","unstructured":"Braude LS, Chandler JW. Atopic corneal disease. Int Ophthalmol Clin. 1984;24:145\u201356.","journal-title":"Int Ophthalmol Clin"},{"key":"456_CR13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/bjd.17869","volume":"181","author":"B Akinlade","year":"2019","unstructured":"Akinlade B, Guttman-Yassky E, de Bruin-Weller M, et al. Conjunctivitis in dupilumab clinical trials. Br J Dermatol. 2019;181:459\u201373.","journal-title":"Br J Dermatol"},{"key":"456_CR14","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1016\/S0140-6736(17)31191-1","volume":"389","author":"A Blauvelt","year":"2017","unstructured":"Blauvelt A, de Bruin-Weller M, Gooderham M, et al. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomized, double-blinded, placebo-controlled phase 3 trial. Lancet. 2017;389:2287\u2013303.","journal-title":"Lancet"},{"key":"456_CR15","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/ACI.0b013e32834a9676","volume":"11","author":"N Rosario","year":"2011","unstructured":"Rosario N, Bielory L. Epidemiology of allergic conjunctivitis. Curr Opin Allergy Clin Imunol. 2011;11:471\u20136.","journal-title":"Curr Opin Allergy Clin Imunol"},{"key":"456_CR16","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1111\/all.13448","volume":"73","author":"J Bousquet","year":"2018","unstructured":"Bousquet J, Devillier P, Anto JM, et al. Daily allergic multimorbidity in rhinitis using mobile technology: a novel concept of the MASK study. Allergy. 2018;73:1622\u201331.","journal-title":"Allergy"},{"key":"456_CR17","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/jdv.15608","volume":"33","author":"JP Thyssen","year":"2019","unstructured":"Thyssen JP, de Bruin-Weller M, Paller AS, et al. Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy\u2014international eczema council survey and opinion. J Eur Acad Dermatol Venereol. 2019;33:1224\u2013311.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"456_CR18","doi-asserted-by":"publisher","first-page":"adv00264","DOI":"10.2340\/00015555-3629","volume":"100","author":"JP Thyssen","year":"2020","unstructured":"Thyssen JP, Heegaard S, Ivert L, et al. Management of ocular manifestations of atopic dermatitis: a consensus meeting using a modified Delphi process. Acta Derm Venereol. 2020;100:adv00264.","journal-title":"Acta Derm Venereol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-020-00456-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-020-00456-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-020-00456-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T12:35:00Z","timestamp":1634042100000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-020-00456-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["456"],"URL":"https:\/\/doi.org\/10.1007\/s13555-020-00456-x","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,12]]},"assertion":[{"value":"5 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}